Rod Ferguson, J.D., Ph.D.
Dr. Ferguson is a co-founder of Panorama Capital, a venture capital firm
which spun off from JPMorgan Partners (JPMP) in July 2006, where he focuses
primarily on life sciences investments. He joined JPMP as a Managing
Director in their life sciences venture practice in 2001. From 1999 to 2001,
Dr. Ferguson was a partner at InterWest Partners, a venture capital firm,
where he focused on life sciences investments. Prior to InterWest, he held a
variety of management positions over an 11-year career at Genentech, Inc.,
most recently as Senior Director of Business and Corporate Development
responsible for worldwide licensing transactions for both technology and
pharmaceutical products. Prior to joining Genentech, Inc. in 1988, Dr.
Ferguson was an associate with the law firm McCutchen, Doyle, Brown, &
Enersen (currently known as Bingham McCutchen llp).
Dr. Ferguson received a B.S. with honors in Biochemistry from the University
of Illinois, a Ph.D. in Biochemistry from the State University of New York
at Buffalo, and a J.D. cum laude from Northwestern University. Dr. Ferguson
serves on the technology advisory board of The Economist, a variety of
advisory boards in the life sciences industry, and two non-profit boards. In
addition, he serves on the board of directors of several private life